Investor Relations

Bausch Health Announces Third Quarter 2024 Results

Read the full Story

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

Read the full Story

Salix Pharmaceuticals Applauds Implementation of K76.82 – a New ICD-10 Code for Hepatic Encephalopathy

Read the full Story

Bausch Health Companies Inc. is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals, and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.

Events and Presentations

Events and Presentations

Details on upcoming events are not yet available. View All
Annual Report

Annual Reports Archive

Email Alerts

Email Alerts

Sign up to receive email alerts whenever Bausch Health Companies Inc. posts new information to the site.

Register
Powered by Sitecore